With sales in free fall, Bayer's new CEO Anderson considers structural change

Anderson faces plenty of tough questions as he has taken over a company that has a massive litigation headache, growing debt and revenues in rapid decline. Investors are calling for a breakup of the company but Bayer’s deep bureaucracy could make change difficult.

Two weeks ago, the company made a preemptive strike, slashing projected revenue in 2023 by 2.5 billion euros ($2.7 billion) and removing much of the suspense from Anderson’s first quarterly presentation.Baye